Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data Oncolytics Biotech Inc ... which more than doubled response rates in ...
Cynthia Malaran originally went to the doctors complaining she had headaches, felt sick, and was suffering from anxiety, but a nurse soon found signs of cancer ...
The phase III SOUND trial randomized patients with early breast cancer and a negative axillary ultrasound to SLNB or no axillary surgery. In the SLNB arm, 13.7% had positive axillary nodes, 5.1% had ...
On Aug. 26, at 32 years old, Howe was diagnosed with stage two invasive ductal carcinoma, a form of breast cancer that she later found had spread to her lymph nodes. In September, she had the lump ...
Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer. A woman with DCIS is ...
In March 2022, she discovered that she had HER2-positive breast cancer, an aggressive form of the disease in which the cancer cells have an abnormally high level of a protein called human ...
1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 3Pancreatic Cancer ...
1Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, People’s Republic of China. 2Biobank of Tumors from Plateau of Gansu Province, The ...